Related Experiment Video
Updated: Jul 10, 2026
14:21
Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
Published on: August 6, 2013
Cigarette smoke and dopaminergic system
Leah R Miller1, Shyamali Mukherjee, Twum A Ansah
1Division of Cancer Biology, Department of Biomedical Sciences, Meharry Medical College, Nashville TN 37208, USA.
Journal of Biochemical and Molecular Toxicology
|November 13, 2007
Summary
Cigarette smoke exposure in guinea pigs increased locomotor activity. This was linked to changes in brain dopamine levels, receptor proteins, and dopamine transporter binding.
Area of Science:
- Neuroscience
- Neuropharmacology
- Behavioral Science
Background:
- Cigarette smoking has been anecdotally linked to improved neurological responses.
- Understanding the neurochemical effects of cigarette smoke is crucial.
Purpose of the Study:
- To investigate the neurochemical and neurobehavioral effects of cigarette smoke (CS) exposure in adult male guinea pigs.
- To explore the impact of CS on dopamine pathways in the brain.
Main Methods:
- Adult male guinea pigs were exposed to acute and chronic cigarette smoke.
- Neurochemical analyses measured dopamine (DA) and DOPAC levels.
- Protein levels and binding capacities of dopamine D1 and D2 receptors were assessed.
- Dopamine transporter (DAT) binding capacity was also evaluated.
Main Results:
- CS exposure enhanced locomotor behavior in guinea pigs.
- Midbrain dopamine levels decreased, while DOPAC levels increased.
- CS elevated dopamine D1 and D2 receptor protein levels.
- D1 receptor binding capacity increased, whereas D2 binding capacity decreased.
- Dopamine transporter (DAT) binding capacity significantly increased.
Conclusions:
- Cigarette smoke exposure alters neurochemical and neurobehavioral responses in the brain.
- Observed changes in dopamine pathways may underlie the enhanced locomotor activity.
- Further research is needed to elucidate the precise mechanisms involved.
Related Concept Videos
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:29Stimulants
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:15Cholinergic Receptors: Nicotinic
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...